Promoter hypermethylation is a well-known mechanism of transcriptional repression of tumor suppressor genes in breast cancer, including BRCA1, APC, CDH1, FANCF, among others, and may provide a complementary pathway of molecular carcinogenesis, independent of mutations [91,92,93,94]. Here, FANCF is linked to breast carcinoma.